Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: Biologically plausible or an epiphenomenon?

查看全文 作　　者：Amna Subhan [1]Butt;Fatima [1]Sharif;Shahab [1]Abid

机构地区：[1]Section of Gastroenterology, Department of Medicine, Aga Khan University Hospital

出　　处：《World Journal of Hepatology》索引2018年第10卷第2期,共10页

摘　　要：Hepatocellular carcinoma(HCC) is a major cause of morbidity and mortality worldwide. Chronic hepatitis C virus infection(HCV) is the most common cause of HCC in many European countries, Japan and Pakistan. Introduction of the new direct acting antivirals(DAAs) has revolutionized the management of HCV worldwide, with high rates of sustained virologic response in patients who could not have tolerated the previous interferon based treatments. However, recently there have been reports raising caution about the long term effects of DAAs, particularly a possible increased risk of HCC. Therefore this review explores the current molecular studies as well as clinical data that investigate the impact of DAAs on occurrence and recurrence of HCC. 关键词：HEPATOCELLULAR carcinoma Direct ACTING ANTIVIRALS HEPATITIS C

相关文献

参考文献（56）
引证文献（4）
耦合文献（0）

参考文献(56)

引证文献(4)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: Biologically plausible or an epiphenomenon?

参考文献(56)

引证文献(4)

用户提示